Richard Scott Struthers
Independent DirectorDr. Richard Scott Struthers, Ph.D. founded Crinetics Pharmaceuticals, Inc. in November 2008 and served as its Chief Executive Officer and President since December 2008 until September 1, 2026. He is an Independent Director of Frazier Life Sciences Acquisition Corp II from September 2026. He is Chairman at Radionetics Oncology, Inc. since October 2021. In 2021, Dr. Struthers co-founded and serves as Board Chair at Radionetics Oncology. Prior to Crinetics, Dr. Struthers served as Senior Director and Head, Endocrinology and Metabolism at Neurocrine Biosciences from 1998 to 2008. Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions for the life sciences and higher education markets and led contract research efforts at Biosym Technologies, from 1992 to 1995, to develop and apply computational tools for drug discovery. In addition, he is a Member of the Board of Directors of the San Diego Entrepreneurs Exchange, which he co-founded in 2009. Dr. Struthers is also a co-Founder of the San Diego Entrepreneurs Exchange, which he has served on the Board of Directors since January 2009. He served as a Director at Crinetics Pharmaceuticals, Inc since November 2008 until September 1, 2026. Dr. Struthers is an author of more than 75 scientific publications. He holds Ph.D. in Physiology and Pharmacology from the University of California, San Diego.
Positions
- Company NameFrazier Life Sciences Acquisition Corp. IIStock CodeFLSCPositionIndependent Director
